JAN 23, 2017 08:13 PM PST

Sniper Precision in the Immune Response to Infection

WRITTEN BY: Kara Marker

The green pus you see if a wound is infected is gross, but it’s also a sign that the immune system has things under control. An enzyme called myeloperoxidase (MPO) has a direct effect on pathogenic cells that almost entirely keeps host cells unaffected, and green pus is just a sign that it’s working.

Image: The enzyme MPO produces an aggressive acid which burns a hole into the bacterial cell envelope and kills the bacterium without damaging the surrounding tissue. Credit: University of Basel, Biozentrum

 

Because of MPO’s ability to single out pathogen cells during an infection, researchers from the University of Basel decided to study the enzyme in more detail. They found that while white blood cells fight infection by releasing hydrogen peroxide, a chemical toxic to bacterial cells, MPO attaches directly to the surface of a pathogen.Then, the enzyme converts the hydrogen peroxide from white blood cells into hypochlorous acid, which is extremely aggressive and instantly kills the pathogen to which MPO is attached with sniper precision.

"As hypochloric acid is so highly reactive, the bomb reacts immediately with the closest biomolecules. It is ignited locally and does not spread to the wider surroundings,” explained Dirk Bumann. “The bacteria die and the surrounding tissue is spared."

Bumann and other researchers studied a rare mutation that causes affected individuals to lack MPO. Only one in about 5000 people lack MPO due to this genetic defect, and for these individuals, hydrogen peroxide is not converted into hypochlorous acid, and so it collects until it leaks out into the blood cells and surrounding tissue, damaging bacteria, blood cells, and nearby tissues.

"The collateral damage of blood cells and tissues without MPO may cause long-term consequences such as accelerated aging and cancer, but this has not yet been systematically investigated," explained Nina Khanna.

The new study findings provide promise for the development of new drugs that boost the MPO presence during an infection. "Currently, only drugs that do the opposite and inhibit MPO are being developed. The reason is that MPO can have negative effects in the case of heart disease," Bumann said.

A key part of the immune response to infection involves killing the invaders without damaging too much host tissue. This study shows that MPO is at the center of the body’s ability to do this, a good sign for researchers in pursuit of new approaches for immunity strengthening therapies.

The present study was recently published in the journal Nature Microbiology.

Source: University of Basel

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
AUG 06, 2018
Immunology
AUG 06, 2018
Maternal Dengue Immunity Protects Against Infant Zika Infection
Maternal Dengue immunity produces CD8+ T cells that protect against fetal Zika infection preventing zika-related malformations....
AUG 15, 2018
Immunology
AUG 15, 2018
Female vs. Male: The Immune Response
There is a genetic sexual conflict in the immune system, with females showing high variation in central genes compared to males....
AUG 27, 2018
Immunology
AUG 27, 2018
Undiscovered Tunnels from Bone Marrow To Brain
Newly discovered tunnels connect bone marrow of the skull directly to lining of the brain to allow for quick access of immune cells to brain damaged tissues....
AUG 29, 2018
Immunology
AUG 29, 2018
Artificial Intelligence Predicts Response to Immunotherapy
Artificial intelligence can process CT scan images to determine biological and clinical information that can predict immunotherapy efficacy thanks to machine learning....
OCT 16, 2018
Drug Discovery
OCT 16, 2018
Immunotherapeutic Targets A Blood-Clotting Protein
Fibrin is a blood protein that normally does not cross to the brain, however, several neurological disorders have a defect in the blood-brain barrier that ...
NOV 05, 2018
Immunology
NOV 05, 2018
Amino Acid Helps to Promote T cells
Scientists at Vanderbilt show that the amino acid glutamine can contribute to a subset of T cell function and activation...
Loading Comments...